6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
Status:
Withdrawn
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-site, 6-month study of an investigational compound in elderly
outpatients, age 65 years old or above, to assess the long-term safety and tolerability of
the compound in the treatment of elderly subjects with Generalized Anxiety Disorder (GAD).